SEC Form 4 · accession 0001209191-18-032563
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent A. Miller
Officer — Chief Medical Officer
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2018 | M | 1,570 | $29.94 | A | 71,658 | D | |
| Common StockF1 | May 21, 2018 | S | 1,570 | $85.00 | D | 70,088 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $29.94 | May 21, 2018 | M | 1,570 | D | — | Apr 9, 2024 | Common Stock | 1,570 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
- F2This stock option was granted on April 9, 2014 and vested in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018.